Navigating pyruvate kinase deficiency today: How can the disease burden and unmet treatment needs be addressed?
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the burden and clinical presentation of pyruvate kinase (PK) deficiency, the current treatment strategies and remaining unmet treatment need, and future approaches to managing the disease.
The experts
Dr Rachael Grace, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA, USA
Dr Hanny Al-Samkari, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Prof. Ami J Shah, Lucile Packard Children’s Hospital Stanford, and Stanford University, Palo…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.